{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:10:08Z","timestamp":1792653008173,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.thromres.2008.03.010","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T08:09:40Z","timestamp":1210838980000},"page":"146-158","source":"Crossref","is-referenced-by-count":11,"title":["Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis"],"prefix":"10.1016","volume":"123","author":[{"given":"J. Eileen","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Giancarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Allegretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pancras","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Ogletree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2008.03.010_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(24)29348-4","article-title":"Administration of a potent antagonist of protease- activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats","volume":"298","author":"Andrade-Gordon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.thromres.2008.03.010_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0049-3848(99)00175-9","article-title":"Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb\/IIIa antagonist, in guinea pigs","volume":"97","author":"Ogawa","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.03.010_bib3","first-page":"252","article-title":"Experimental carotid thrombosis in the guinea pig","volume":"71","author":"Roux","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0049-3848(97)00308-3","article-title":"Comparison of the antithrombotic effects of FK633, GPIIb\/IIIa antagonist, and aspirin in a guinea pig thrombosis model","volume":"89","author":"Aoki","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.03.010_bib5","first-page":"502","article-title":"Antithrombotic effects of TAK-029, a novel GPIIb\/IIIa antagonist, in guinea pigs: Comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban","volume":"277","author":"Kawamura","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.thromres.2008.03.010_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.jcbfm.9600009","article-title":"FK419, a novel nonpeptide GPIIb\/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban","volume":"25","author":"Moriguchi","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.thromres.2008.03.010_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(98)00328-8","article-title":"Antithrombotic effects of YM-60828 in three thrombosis models in guinea pigs","volume":"350","author":"Sato","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.010_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.CIR.91.5.1568","article-title":"Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis","volume":"91","author":"Carteaux","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2008.03.010_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood.V82.1.126.bloodjournal821126","article-title":"Artificial microvascular graft thrombosis: the consequences of platelet membrane glycoprotein Ib inhibition and thrombin inhibition","volume":"82","author":"Dascombe","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.03.010_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-2999(93)90119-3","article-title":"Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig","volume":"231","author":"Hirata","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.010_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(03)01973-3","article-title":"Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig","volume":"473","author":"Kato","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.010_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(01)00904-9","article-title":"Thromboxane A2 synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding","volume":"417","author":"Kawano","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.010_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(02)01415-2","article-title":"Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb\/IIIa antagonist","volume":"439","author":"Moritani","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.010_bib14","first-page":"62","article-title":"Nonpeptide glycoprotein IIb\/IIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217","volume":"278","author":"Cook","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.thromres.2008.03.010_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0037-1615608","article-title":"Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig","volume":"85","author":"Himber","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1614136","article-title":"S-nitrosoderivative of a recombinant fragment of von willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model","volume":"84","author":"Gurevitz","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1055\/s-0038-1657701","article-title":"Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function","volume":"78","author":"Himber","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.106.119156","article-title":"Biomarker optimization to track the antithrombotic and haemostatic effects of clopidogrel in rats","volume":"322","author":"Schumacher","year":"2007","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1016\/j.thromres.2008.03.010_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.03.010_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.39.5.654","article-title":"Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use","volume":"39","author":"Lanas","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2008.03.010_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.292.15.1867","article-title":"Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease","volume":"292","author":"Tran","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2008.03.010_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2008.03.010_bib23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blind, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2008.03.010_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/s-0038-1650689","article-title":"Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients","volume":"76","author":"Boneu","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib25","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2008.03.010_bib26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2008.03.010_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2007-1002719","article-title":"Development of hirudin as an antithrombotic agent","volume":"15","author":"Markwardt","year":"1989","journal-title":"Semin thromb hemost"},{"key":"10.1016\/j.thromres.2008.03.010_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1381612023395664","article-title":"Leech thrombin inhibitors","volume":"8","author":"Salzet","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.thromres.2008.03.010_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta -analysis of two prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.03.010_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1378\/chest.126.3_suppl.513S","article-title":"Antithrombotic therapy for coronary artery disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Harrington","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2008.03.010_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-3848(98)00213-8","article-title":"Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat","volume":"94","author":"Elg","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.03.010_bib32","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2008.03.010_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00005344-199607000-00004","article-title":"Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time","volume":"28","author":"Schumacher","year":"1996","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:33:10Z","timestamp":1738225990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384808000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0049384808000959"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2008.03.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}